Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Trader J's Inner Circle -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (4112)	1/12/1999 6:55:00 PM
From: Canuck Dave	Read Replies (1) \| Respond to of 56532

Three items of note from the Vancouver Sun. 1. Apparently, the Vancouver Stock Exchange (called by Barron's in 1987 the scam capital of the world) has tightened up its reporting and disclosure regulations to the point where the paper artists have moved on to greener pastures. Guess which exchange most of them have gone to. 2. Maylasia has strong growth again, Japan recorded its first growth month in 2 years and the Hong Kong exchange is at an eight month high. Asia might be turning around. 3. Demand for Canadian resource sector products jumped in the last week, pushing up the base metal index particularly. There might be some real undiscovered gems on the VSE.... CD

To: Mike McFarland who wrote (4112)	1/12/1999 8:45:00 PM
From: Poet	Read Replies (1) \| Respond to of 56532

Really good post on the biotechs, Mike. I've not been following them so this kind of synopsis is valuable to me. And I liked the "sea of red" allusion too!

To: Mike McFarland who wrote (4112)	2/3/1999 1:08:00 AM
From: Mike McFarland	Read Replies (3) \| Respond to of 56532

Genomics stocks--a followup to a post from a few weeks ago... Since I last entered a little summary on the stock price movement in this category of stocks...we have seen not a lot of change--the winners kept running, the losers kept falling...and the boring stocks in this category--well they've stayed pretty boring. (The reference/url to which I am referring is in the post to which this is linked) or if you're curious go directly to my last genomics post here: Message 7246797 And here is the followup: GENXY still continus to give ground, now 21 1/2 it has fallen through most of the 20's slow and steady. MYGN, ENZ, HGSI, GENE...nothing going on as far as I can tell, stocks pretty lifeless, but steady. AFFX had run to $30 when I'd last checked a few weeks ago...now it's up near $40--earnings just out, loss of 30 cents, in line with expectations I'm pretty sure, since nothing magical happened I'd expect it to give ground now with some of the momo players cashing out. INCY...back in mid-January this one was in the 30s, now it's going to test $20...hard to beleive, earnings out very soon--one to watch! For what it is worth, if you go to the research on Yahoo you will see a 1.4 (5,1,1,0,0) recommendation score on Incyte--not too shabby, but down from 1.0 last week. AFFX only shows a 2.2 (0,5,1,0,0) but that has ticked up from last week 0.1. I'm almost far enough in to my due diligence as they say to pick one of these genomics companies for my portfolio. If/when I get around to making the trade, you can be sure I'll post it. It may not even be Incyte...but rather one of the third tier genomic/bioinformatics/proteomic stocks--which would be in keeping with my bottomfishing strategy. Note that MLNM is not on my list, maybe it should be, but it has had such a run I sort of figure it will have a lot of profit-taking one day. There are several other stocks which have done nothing, and I'll get to them next post or if they show some life. And as far as trading lately, not too much going on for me, sitting on some things and letting them cook--and paper trading again while the market seems to be weak. --Mike